• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TINA-QUANT HBALC GEN. 3; ASSAY, GLYCOSYLATED HEMOGLOBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TINA-QUANT HBALC GEN. 3; ASSAY, GLYCOSYLATED HEMOGLOBIN Back to Search Results
Model Number HBA1C TQ G3
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/02/2023
Event Type  malfunction  
Manufacturer Narrative
On (b)(6) 2023 a mechanism check was performed with acceptable results.The gear pump pressure, cell rinse tubing, and cell cover were all acceptable.It was noted that the sample probe rinse station had blood stains.Precision results and qc were acceptable."abnormal aspiration", "sample duplication" and "clot detection" errors were observed on the alarm trace data.The photometer lamp was last replaced on (b)(6) 2023.The sample probe was last replaced and adjusted on (b)(6) 2023.Cells were last replaced on (b)(6) 2023.The investigation did not identify a product problem.The investigation determined the event was consistent with sample quality issues or contamination of the sample probe.
 
Event Description
The initial reporter complained of discrepant results for 1 patient sample tested for tina-quant hba1c gen.3 (hba1c) on a cobas 8000 c 502 module.The initial result from the c502 module was 7.89%.This result was reported outside of the laboratory where the doctor complained as the patient had an hba1c of 5.7% on an unspecified point-of-care instrument.On (b)(6) 2023 the sample was repeated on the c502 module with a result of 5.66%.The c502 module serial number was (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TINA-QUANT HBALC GEN. 3
Type of Device
ASSAY, GLYCOSYLATED HEMOGLOBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16460309
MDR Text Key310440101
Report Number1823260-2023-00622
Device Sequence Number1
Product Code LCP
UDI-Device Identifier04015630926275
UDI-Public04015630926275
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
K102914
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2024
Device Model NumberHBA1C TQ G3
Device Catalogue Number05336163190
Device Lot Number695526
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/04/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age74 YR
Patient SexMale
-
-